67 results
Posted on 26.10.2020
The implications of COVID-19 on recruiting in the Life Science sector
We’re at the heart of the global response to COVID-19, a powerful reminder of our mission to enable our customers to make the world healthier,cleaner and safer. What’s driving us every day is the feeling that there is a meaning to our work over and beyond the reward of the paycheck. What’s compelling now is […]
Posted on 21.09.2020
EU Health PPP: a new era for medtech companies
For decades, companies in the medtech and pharma sectors have delivered healthcare innovations separately – collaboration has been limited. However, we know that this is not how patients experience healthcare. In the real world, diagnostics, devices, medicines, vaccines and digital tools combine to keep people healthy and to treat those who are unwell. This reality […]
Posted on 03.09.2020
COVID-19 & diagnostics: lessons on how to extract value from data
This is the second in a two-part series. Read part one. The link between clinical and social aspects of COVID-19 raises the question of what type of data are needed to manage the COVID-19 surge and better absorb shocks that may be caused by future pandemics. We believe clinical patient level data are essential given […]
Posted on 27.08.2020
COVID-19 & diagnostics: the value of ‘test, test, test’
The power of diagnostics information (VODI) to public health and society was a topic of keen interest even before the COVID-19 outbreak. The pandemic offers us fresh lessons on how health systems can harness this value. Many of us will recall one of the earliest recommendation from the Director General of the WHO during the […]
Posted on 22.05.2020
Closing the innovation loop: how start-ups can show value
One of my great frustrations is to see start-ups fall at the final hurdle. Too many early-stage companies with promising innovations spend their energy – and funds – answering crucial questions about the safety and effectiveness of their products, only to find that they have no answers to the additional questions asked by payers. […]
Posted on 20.05.2020
Medtech role in the global response to the COVID-19
This blog is part of a blog series that showcases the medtech role in the different phases of the COVID-19 pandemic. Read here more COVID-19 related blogs. More info on MedTech Europe’s info hub. The medical technology industry have played a pivotal role in the global response to the COVID-19 pandemic. Now it will be central […]
Posted on 29.04.2020
Maximising the potential of diagnostic information in heart failure care
Covid-19 has proven a seismic event for our societies, and it is easy to forget that the pandemic will not dominate the debate on healthcare forever. Yet by any rational measure, efforts to manage long-term conditions will continue to be responsible for the majority of healthcare costs into the future. Heart failure (HF) is, and […]
Posted on 15.11.2019
Prevention is better than cure: it’s time we value diagnostic information
Prevention is better than cure. It’s cheaper too. In fact, preventing future illnesses and preventing complications from existing conditions, are vital to the future sustainability of health systems. For a vaccine that prevents measles, or a medication that prevents a heart attack, the value is obvious. But what about the value of learning that you […]
Posted on 03.10.2019
Training patients to engage in medtech R&D
The European Patients’ Academy (EUPATI) has trained dozens of patients to engage with companies and decision-makers on medicines development. Now it’s time to think about medtech. I am convinced that the days when experts and clinicians decided what patients want are long gone. Modern healthcare aspires to be patient-centred, while academics, policymakers and industry are […]